Perrigo Company plc (PRGO)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$16.05
+1.42%
Mkt Cap $2.21B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$36.20
Range $20.00 – $54.00
Implied Upside
+125.6%
Consensus $36.20 vs current $16.05